A detailed history of Resolute Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Resolute Financial, LLC holds 5,668 shares of ABT stock, worth $656,921. This represents 0.53% of its overall portfolio holdings.

Number of Shares
5,668
Previous 5,375 5.45%
Holding current value
$656,921
Previous $520,000 19.62%
% of portfolio
0.53%
Previous 0.49%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $27,852 - $32,675
293 Added 5.45%
5,668 $622,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $96 - $112
1 Added 0.02%
5,375 $520,000
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $204 - $246
2 Added 0.04%
5,374 $584,000
Q1 2022

Apr 15, 2022

SELL
$114.02 - $139.04 $77,419 - $94,408
-679 Reduced 11.22%
5,372 $636,000
Q4 2021

Feb 15, 2022

BUY
$115.53 - $141.46 $699,072 - $855,974
6,051 New
6,051 $852,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Resolute Financial, LLC Portfolio

Follow Resolute Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Financial, LLC with notifications on news.